comparemela.com
  1. Home
  2. Live Updates
  3. Drs Strizki - Breaking News

Latest Breaking News On - Drs strizki - Page 1 : comparemela.com

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial | Infectious Diseases | JAMA

This randomized clinical trial compares the efficacy and safety of letermovir vs valganciclovir prophylaxis for cytomegalovirus (CMV) disease in CMV-seronegativ

United statesUniversity of washingtonSan diegoAjitp limayeMerck co incMerck coEuropean medicines agencyAmerican society of nephrology kidney weekGilead sciencesMerck sharp dohmeAmerican transplant congressDrug administrationGood clinical practiceInternational conferenceHarmonization guidelineSecondary efficacy outcomes

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.